Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

August 15, 2017

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
Metastatic Breast Cancer
Interventions
DRUG

Seribantumab

Seribantumab is a human monoclonal antibody that inhibits ErbB3 signalling

DRUG

Fulvestrant

Fulvestrant is an estrogen receptor antagonist with no agonist effects

DRUG

Placebo

Placebo

Trial Locations (59)

1090

Medizinische Universität Wien, Vienna

1200

Cliniques Universitaires Saint-Luc, Brussels

1340

Clinique Saint-Pierre, Ottignies

2650

Universitair Ziekenhuis Antwerpen, Antwerp

3000

Universitaire Ziekenhuis Leuven, Leuven

4010

Krankenhaus der Barmherzigen Schwestern Linz, Linz

5000

CHU UCL NAMUR - Sainte Elisabeth, Namur

6020

Universitaetsklinik fuer Gynaekologie und Geburtshilfe, Innsbruck

6800

Centre Hospitalier de l'Ardenne - Clinique du Sein, Libramont

8036

LKH - Universitätsklinikum Graz, Graz

15006

Complejo Hospitalario Universitario La Coruña, A Coruña

Hospital Teresa Herrera, A Coruña

15232

UPMC Cancer Center, Pittsburgh

17007

Hospital Universitari de Girona Doctor Josep Trueta, Girona

20902

Holy Cross Hospital Health Center, Silver Spring

21701

James M Stockman Cancer Institute, Frederick

23007

Complejo Hospitalario de Jaén, Jaén

25198

Hospital Universitari Arnau de Vilanova, Lleida

27599

Lineberger Comprehensive Cancer Center, Chapel Hill

28007

Hospital General Universitario Gregorio Marañón, Madrid

28034

Hospital Universitario Ramón Y Cajal, Madrid

28040

Hospital Clínico San Carlos, Madrid

28046

Hospital Universitario La Paz, Madrid

28207

Oncology Specialists of Charlotte, Charlotte

29010

Hospital Universitario Virgen de la Victoria, Málaga

30177

Gynäkologisch-Onkologische Praxis Hannover, Hanover

31904

Columbus Regional Research Institute, Columbus

32806

UF Health Cancer Center at Orlando Health, Orlando

33136

Sylvester Comprehensive Cancer Center, Miami

33612

Moffitt Cancer Center, Tampa

39216

University of Mississippi, Jackson

41009

De La Cruz Merino, Luis, Seville

46010

Hospital Clínico Universitario de Valencia, Valencia

53111

Medizinisches Zentrum Bonn Friedensplatz, Bonn

53840

Onkologie Rheinsieg, Troisdorf

59009

Hospital Universitario Miguel Servet, Zaragoza

62526

Cancer Care Specialists of Central Illinois, Decatur

65804

Mercy Hospital Springfield, Springfield

68803

Saint Francis Cancer Treatment Center, Grand Island

72703

Highland Oncology Group, Fayetteville

80637

Rotkreuzklinikum München-Frauenklinik, Munich

81675

Klinikum Rechts der Isar der Technischen Universität München, München

84112

University of Utah Health Care - Huntsman Cancer Institute, Salt Lake City

85224

Ironwood Cancer and Research Centers- Chandler, Chandler

89075

Universitätsklinikum Ulm, Ulm

91054

Universitätsklinikum Erlangen, Erlangen

94304

Stanford University, Palo Alto

94574

Saint Helena Hospital, St. Helena

90404-2131

Beverly Hills Cancer Center, Beverly Hills

06902-3628

Stamford Hospital, Stamford

01805

Lahey Clinical Medical Center, Burlington

03756

Dartmouth Hitchcock Medical Center, Lebanon

T2S 3C3

University of Calgary, Calgary

V1Y 5L3

British Columbia Cancer Agency, Kelowna

H3T 1E2

McGill University - Jewish General Hospital, Montreal

G1S 4L8

Centre Hospitalier Affilie Universitaire de Quebec, Québec

Unknown

Centrum fuer Haematologie und Onkologie Bethanien, Frankfurt

08190

Hospital Universitari General de Catalunya, Sant Cugat del Vallès

07198

Hospital Son Llatzer, Palma de Mallorca

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Elevation Oncology

INDUSTRY